Abpro Holdings (ABPO) EPS (Basic) (2022 - 2026)
Abpro Holdings' (ABPO) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, down 186.78% YoY from $0.25 in Q1 2025, and up 74.87% on a QoQ basis from -$0.87 in Q4 2025.
Abpro Holdings (ABPO) EPS (Basic) (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of EPS (Basic) data on file, last reported at -$0.22 in Q1 2026.
- Quarterly EPS (Basic) fell 186.78% year-over-year to -$0.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.54 (down 928.09% YoY) and the FY2025 annual result came in at -$1.3, down 74.19% from the prior year.
- EPS (Basic) climbed to -$0.22 in Q1 2026, from -$0.87 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.07 in Q1 2023 to a low of -$0.87 in Q4 2025.
- A 5-year average of -$0.11 and a median of -$0.04 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 931.63% — and 2024, when it tumbled 20160.03%.
- Tracing ABPO's EPS (Basic) over 5 years: stood at $0.05 in 2022, then plunged by 101.26% to -$0.0 in 2023, then slumped by 20160.03% to -$0.13 in 2024, then sank by 568.44% to -$0.87 in 2025, then surged by 74.87% to -$0.22 in 2026.
- The last three EPS (Basic) figures came in at -$0.22 (Q1 2026), -$0.87 (Q4 2025), and -$0.59 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -0.59 |
| Jun 30, 2025 | -0.04 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | -0.05 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -0.04 |